HeartBeamBEATW 26 Interest Coverage is No Debt (1) as of Mar. 2026, which is 100% below its 10-year median of 10,000.00. GuruFocus rates BEATW with a GF Score™ of 26/100. The stock has 2 warning signs investors should review. Among 452 Healthcare Providers & Services companies, HeartBeam ranks better than 99.56% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. HeartBeam's
Operating Income
for the
three
months ended in Mar. 2026 was $-4.72 Mil. HeartBeam's Interest Expense for the
three
months ended in Mar. 2026 was $0.00 Mil.
HeartBeam has no debt.
The higher the ratio, the stronger the company's financial strength is.
Good Sign:
HeartBeam Inc has no debt.
(1) Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
The historical rank and industry rank for HeartBeam's Interest Coverage or its related term are showing as below:
BEATW'
s Interest Coverage Range Over the Past 10 Years
Min: No Debt Med: No Debt Max: No Debt
Current: No Debt
BEATW's Interest Coverage is ranked better than 99.56% of 452
companies
in the Healthcare Providers & Services industry
Industry Median: 7.99
vs BEATW: No Debt
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
HeartBeam Interest Coverage Related Terms
HeartBeam Interest Coverage Historical Data
* Premium members only.
The historical data trend for HeartBeam's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
BEATW vs ONMD, DRIO, VASO: Interest Coverage Comparison
For the Health Information Services subindustry, HeartBeam's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
HeartBeam Interest Coverage vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, HeartBeam's Interest Coverage distribution charts can be found below:
* The bar in red indicates where HeartBeam's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Interest Coverage of No Debt <sup>(1)</sup> mean?
HeartBeam (BEATW) has a Interest Coverage of No Debt (1) as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on HeartBeam and its competitors. This is 100% below median its historical median of 10,000.00. Over the past decade, HeartBeam's Interest Coverage has ranged from 10,000.00 to 10,000.00. According to the industry distribution chart, HeartBeam ranks #2 out of 452 companies in the Healthcare Providers & Services industry, placing it in the top 0.40000000000001%.
Is HeartBeam's Interest Coverage too high?
HeartBeam's current Interest Coverage of No Debt (1) is 100% below median its 10-year median of 10,000.00. Over the past 10 years, this metric has ranged from a low of 10,000.00 to a high of 10,000.00. Based on the distribution chart, HeartBeam ranks #2 out of 452 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, HeartBeam has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does HeartBeam's Interest Coverage compare to ONMD and DRIO?
According to the Healthcare Providers & Services industry distribution chart, HeartBeam ranks #2 out of 452 companies for Interest Coverage. This places HeartBeam in the top 0% of its industry — outperforming the majority of peers. The industry median Interest Coverage is 7.99. Historically, HeartBeam's own Interest Coverage has ranged from 10,000.00 to 10,000.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Healthcare Providers & Services company?
The median Interest Coverage among Healthcare Providers & Services companies is 7.99, based on 452 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on HeartBeam and its competitors. For the Healthcare Providers & Services industry, the median Interest Coverage is 7.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. HeartBeam's current Interest Coverage is No Debt (1), which is 100% below median its own 10-year median of 10,000.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HeartBeam stock overvalued right now?
HeartBeam (BEATW) has a current Interest Coverage of No Debt (1). The current Interest Coverage is No Debt (1), which is 100% below median its 10-year median of 10,000.00. HeartBeam's overall GF Score™ is 26/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For HeartBeam (BEATW), the current Interest Coverage is No Debt (1) as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
HeartBeam Inc is a medical technology company focused on developing higher resolution ambulatory electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The company's proprietary and patented technology platform captures the heart's electrical activity from three dimensions and synthesizes a 12-lead ECG from these signals. The company has received U.S. Food and Drug Administration (FDA) clearance for its ECG solutions.
26GF Score
Get the complete analysis for BEATW
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BEATW has been successfully added to your 
